Efficacy of menatetrenone (vitamin k2) against non-vertebral and hip fractures in patients with neurological diseases: Meta-analysis of three randomized, controlled trials

Jun Iwamoto, Hideo Matsumoto, Tsuyoshi Takeda

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background and objective: Patients with neurological diseases such as Alzheimer's disease, stroke and Parkinson's disease have been reported to have vitamin K deficiency secondary to malnutrition, which increases the risk of non-vertebral and hip fractures. The purpose of the present study was to clarify the efficacy of menatetrenone (vitamin K2) against non-vertebral and hip fractures in patients with neurological diseases. Methods: A literature search was conducted on PubMed from January 1995 to July 2008 to identify randomized controlled trials (RCTs) of use of menatetrenone against non-vertebral and hip fractures in patients with neurological diseases. A meta-analysis of all RCTs meeting these criteria was then performed. Results: Three RCTs of patients with Alzheimer-disease (n = 178, mean age 78 years), stroke (n = 99, mean age 66 years) and Parkinson's disease (n = 110, mean age 72 years) met the criteria for meta-analysis. These RCTs did not include placebo controls but did have non-treatment controls. According to the meta-analysis, the overall relative risks (95% confidence intervals) for non-vertebral and hip fractures with menatetrenone treatment compared with non-treatment were 0.13 (0.05, 0.35) and 0.14 (0.05, 0.43), respectively, in patients with neurological diseases. No severe adverse events were reported with menatetrenone treatment. Conclusion: The present meta-analysis of three RCTs suggests that there is efficacy for menatetrenone treatment against non-vertebral and hip fractures among patients with neurological diseases. Further larger placebo-controlled trials are needed to confirm the results of the present study.

Original languageEnglish
Pages (from-to)471-479
Number of pages9
JournalClinical Drug Investigation
Volume29
Issue number7
DOIs
Publication statusPublished - 2009 Jan 1

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Efficacy of menatetrenone (vitamin k<sub>2</sub>) against non-vertebral and hip fractures in patients with neurological diseases: Meta-analysis of three randomized, controlled trials'. Together they form a unique fingerprint.

  • Cite this